Mary E. Corbett

The Broadlane Group, Inc. provides business and logistics consulting services for the healthcare industry. It offers supply chain management, strategic sourcing of supplies, professional sourcing, clinical workforce optimization, clinical and lean process consulting, operations and capital equipment lifecycle management solution. The company was founded in 1999 and is headquartered in Dallas, TX.

Synexus Compass, Inc. provided medical image-analysis, subject-recruitment and biochemical marker services that enable life-science industry clients to execute clinical trials while decreasing the time, uncertainty and cost of product development. The company was founded in 1998 and was headquartered in San Francisco, CA.

myCFO, Inc. provides wealth planning and investment management services. The private company is based in Redwood City, CA. The company was founded by James H. Clark.

The Ketera Network TM transforms business buying and selling by integrating an enterprise-class spend management solution and an active community of 250,000 business buyers and suppliers that have transacted over $4 billion in spend and actively collaborate to improve results. Using the Ketera Network, the procurement organization can improve the efficiency and effectiveness of their entire source-to-pay process with its enterprise-class spend management capabilities that includes sourcing, contract management, procurement, invoicing and spend analytics. In addition, the Network's supplier discovery and marketing tools help suppliers grow their business and enable buying organizations find better suppliers. Finally, its network-level analytics enable buying organizations and suppliers to benchmark and improve their business strategies. By simultaneously delivering considerable cost savings for buyers and new business opportunities for suppliers, the Ketera Network represents the next generation of business applications that benefit from a strong community multiplier effect. Ketera is located in San Jose, CA. The company has blue chip investors including Kleiner Perkins Caufield & Byers, Foundation Capital, Integral Capital Partners, Emergence Capital Partners, and American Express.

Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Verinata Health, Inc. focuses on maternal and fetal health. It develop and offer non-invasive tests for early identification of fetal chromosomal abnormalities. The firm's products include 'verifi' prenatal test, a non-invasive test that detects three primary aneuploidies for trisomies 21, 18 and 13 from a single maternal blood draw as early as 10 weeks and 'Monosomy X', a test for Turner syndrome. The company was founded by Michael D. Grisham and Richard P. Rava in 2001 and is headquartered in San Diego, CA.